| Price | 9.35p on 17-04-2026 at 18:50:09 |
|---|---|
| Change | 0.15p 1.63% |
| Buy | 9.50p |
| Sell | 9.20p |
| Last Trade: | Sell 150,000.00 at 9.20p |
| Day's Volume: | 827,486 |
| Last Close: | 9.35p |
| Open: | 9.35p |
| ISIN: | GB00BYV81293 |
| Day's Range | 9.35p - 9.35p |
| 52wk Range: | 2.25p - 12.35p |
| Market Capitalisation: | £99.90m |
| VWAP: | 9.245426p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 150,000 | 9.20p | Ordinary |
16:40:55 - 17-Apr-26 |
| Sell* | 32,250 | 9.29p | Ordinary |
16:03:45 - 17-Apr-26 |
| Unknown* | 21,348 | 9.35p | Ordinary |
16:01:30 - 17-Apr-26 |
| Sell* | 48,396 | 9.29p | Ordinary |
15:51:11 - 17-Apr-26 |
| Sell* | 100,000 | 9.305p | Ordinary |
15:47:55 - 17-Apr-26 |
| Sell* | 43,243 | 9.25p | Ordinary |
15:19:41 - 17-Apr-26 |
| Sell* | 50,000 | 9.26p | Ordinary |
15:13:13 - 17-Apr-26 |
| Sell* | 50,000 | 9.20p | Ordinary |
15:12:57 - 17-Apr-26 |
| Sell* | 100,000 | 9.22p | Ordinary |
14:50:27 - 17-Apr-26 |
| Sell* | 33,154 | 9.22p | Ordinary |
14:24:40 - 17-Apr-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
| 9th Feb 2026 7:00 am | RNS | FDA Grants additional Exclusivity for ACCRUFeR |
| 30th Jan 2026 7:05 am | RNS | Total Voting Rights |
| 30th Jan 2026 7:00 am | RNS | Approval for ACCRUFeR in China expected in Q1 2026 |
| 21st Jan 2026 7:00 am | RNS | Q4 2025 Trading Update |
